Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00364871 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity
A Phase 2 study, sponsored by Orexigen Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 410
- Enrollment target
NCT00364871: Completed Phase 2 study, sponsored by Orexigen Therapeutics.
NCT00364871 is a Phase 2 study that has completed, run by Orexigen Therapeutics. The registered enrollment target is 410 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (208% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00364871, a Phase 2 study, has completed, sponsored by Orexigen Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 410 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy and safety of 3 combinations of naltrexone and bupropion SR compared to naltrexone alone, bupropion SR alone or placebo.
Interventions
- DRUG naltrexone and bupropion SR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 410 participants |
| Start Date | 2005-04 |
| Est. Completion | 2007-03 |
| Phase | Phase 2 |
What the finished NCT00364871 record still lists
NCT00364871 is an interventional study that assigns participants to a tested intervention. The registered 410 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (208% higher).
The record links to 0 conditions, and to 1 intervention - of which naltrexone and bupropion SR is the first listed.
NCT00364871 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00364871 about?
NCT00364871 is a clinical study titled "Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity". The purpose of this study is to determine the efficacy and safety of 3 combinations of naltrexone and bupropion SR compared to naltrexone alone, bupropion SR alone or placebo.
What is the current status of trial NCT00364871?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 410 participants. The study started on 2005-04. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00364871?
The interventions under investigation include: naltrexone and bupropion SR (DRUG).
Who is sponsoring clinical trial NCT00364871?
This trial is sponsored by Orexigen Therapeutics, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00364871's enrollment target sits among peer trials
410 93rd of 2000 higher than 1,908 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
- NCT05730036 · 410 participants · Phase 3
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
- NCT05751473 · 410 participants · NA
Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia